Phosgene Oxime Exposure Workup

1. Armstrong J. Chemical warfare. RN. 2002 Apr. 65(4):32-9. [Medline].

2. Dang C. Chemical warfare agents. Top Emerg Med. 2002. 24(2):25-39.

3. McManus J, Huebner K. Vesicants. Crit Care Clin. 2005 Oct. 21(4):707-18, vi. [Medline].

4. Rosenbloom M, Leikin JB, Vogel SN, Chaudry ZA. Biological and chemical agents: a brief synopsis. Am J Ther. 2002 Jan-Feb. 9(1):5-14. [Medline].

5. Department of the Army. Phosgene oxime. Field Manual 8-285: Treatment of Chemical Agent Casualties and Conventional Military Chemical Injuries. 1995. IV-17-22.

6. Zajtchuk R, Bellamy RF, eds. Phosgene oxime. Textbook of Military Medicine Part I: Medical Aspects of Chemical and Biological Warfare. 1997. 220-222.

7. Goswami DG, Agarwal R, Tewari-Singh N. Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite. Toxicol Lett. 2018 Sep 1. 293:112-119. [Medline].

8. McAdams AJ Jr, Joffe MH. A Toxico-pathologic Study of Phosgene Oxime. 1955.

9. Tewari-Singh N, Goswami DG, Kant R, Croutch CR, Casillas RP, Orlicky DJ, et al. Cutaneous exposure to vesicant phosgene oxime: Acute effects on the skin and systemic toxicity. Toxicol Appl Pharmacol. 2017 Feb 15. 317:25-32. [Medline].

10. Hurst CG, Petrali JP, Barillo DJ, Graham JS, Smith WJ, Urbanetti JS, et al. Vesicants. Tuorinsky SD. Medical Aspects of Chemical Warfare. 1st. Washington, D.C.: Office of the Surgeon General, Textbook of Military Medicine; 2008. 259-310. [Full Text].

11. Russell D, Blain PG, Rice P. Clinical management of casualties exposed to lung damaging agents: a critical review. Emerg Med J. 2006 Jun. 23(6):421-4. [Medline].

12. [Guideline] Agency for Toxic Substances & Disease Registry (ATSDR). Medical management guidelines for phosgene oxime. ATSDR.cdc.gov. Available at http://www.atsdr.cdc.gov/MHMI/mmg167.pdf. October 21, 2014; Accessed: March 1, 2019.

13. USAMRICD. Phosgene oxime. Medical Management of Chemical Casualties Handbook. 3rd ed. 2000. 96-101.

Erik D Schraga, MD Staff Physician, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates

Disclosure: Nothing to disclose.

Andre Pennardt, MD, FACEP, FAAEM, FAWM Professor and Vice Chairman for Operational Medicine, Department of Emergency Medicine and Hospitalist Services, Georgia Regents University

Andre Pennardt, MD, FACEP, FAAEM, FAWM is a member of the following medical societies: American Academy of Emergency Medicine, American Medical Association, Florida Medical Association, National Association of EMS Physicians, Special Operations Medical Association, International Society for Mountain Medicine, American College of Emergency Physicians, Association of Military Surgeons of the US, Wilderness Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Zygmunt F Dembek, PhD, MPH, MS, LHD Associate Professor, Department of Military and Emergency Medicine, Adjunct Assistant Professor, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine

Zygmunt F Dembek, PhD, MPH, MS, LHD is a member of the following medical societies: American Chemical Society, New York Academy of Sciences

Disclosure: Nothing to disclose.

Fred Henretig, MD Director, Section of Clinical Toxicology, Professor, Medical Director, Delaware Valley Regional Poison Control Center, Departments of Emergency Medicine and Pediatrics, University of Pennsylvania School of Medicine, Children's Hospital

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article